Novartis’ pelacarsen failed to reduce cardiovascular events despite lowering the harmful cholesterol Lp(a). The setback raises uncertainty for rival experimental Lp(a) drugs from Amgen and Eli Lilly.
The 2x EXP multiplier itself does not stack above 2x. Redeeming another EXP code extends the duration of the same boost instead, so several codes can be used to keep 2x EXP running for a longer ...